Article
HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Mar 2013
Laitinen Virpi H, Wahlfors Tiina, Saaristo Leena, Rantapero Tommi, Pelttari Liisa M, Kilpivaara Outi, Laasanen Satu-Leena, Kallioniemi Anne, Nevanlinna Heli, Aaltonen Lauri, Vessella Robert L, Auvinen Anssi, Visakorpi Tapio, Tammela Teuvo L J, Schleutker Johanna
Abstract excerpt
BACKGROUND: A recently identified germline mutation G84E in HOXB13 was shown to increase the risk of prostate cancer. In a family-based analysis by The International Consortium for Prostate Cancer Genetics (ICPCG), the G84E mutation was most prevalent in families from the Nordic countries of Finland (22.4%) and Sweden (8.2%). METHODS: To further investigate the importance of G84E in the Finns, we determined its...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
